<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00295620</url>
  </required_header>
  <id_info>
    <org_study_id>1033AU/0003</org_study_id>
    <secondary_id>ABCSG 16</secondary_id>
    <secondary_id>D5392L00016</secondary_id>
    <secondary_id>SALSA</secondary_id>
    <nct_id>NCT00295620</nct_id>
  </id_info>
  <brief_title>Secondary Adjuvant Long Term Study With Arimidex</brief_title>
  <acronym>SALSA</acronym>
  <official_title>A Prospective, Randomized, Open, Multicentre Phase III-study to Assess the Efficacy of Secondary Adjuvant Endocrine Anastrozole Therapy for 2 Further Yrs vs 5 Further Yrs in Patients With HR +ve Breast Cancer After 5-yr Primary Adjuvant Endocrine Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study assesses the effect of further 2 years vs further 5 years of adjuvant treatment
      with anastrozole after initial 5 years of adjuvant endocrine therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ABCSG 16 S.A.L.S.A is assessing the effect of further 2 years vs further 5 years of adjuvant
      treatment with anastrozole after initial 5 years of adjuvant endocrine therapy. S.A.L.S.A. is
      a randomized open multicentered phase III study comparing the efficacy of secondary adjuvant
      endokrine treatment of Arimidex® (Anastrozol) for 2 or 5 years after primary adjuvant
      endokrine therapy in patients with hormonreceptor positive mammakarzinom. Patients are
      examined at screening, after 6 months, then every year until 5 years. The subsequent yearly
      follow up with mammographie and clinical examination ends 10 years after the screening.
      S.A.L.S.A. started in February 2004 and has recruited 3484 patients until June 2010 at 78
      sites all over Austria.

      Primary Endpoint:

      1. Proof of the effect of 2 years versus 5 years of Anastrozol after 5 years of adjuvant
      endocrine therapy on the disease free survival

      Secondary endpoint:

        1. Proof of the effect of 2 years versus 5 years of Anastrozol after 5 years of adjuvant
           endocrine therapy on the overall survival

        2. Comparison of fracture rate in both therapy groups

        3. Comparison of incidence of

             1. a secondary carcinoma except the contralateral mammacarcinoma

             2. contralateral mammacarcinoma in both therapie groups
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2004</start_date>
  <completion_date type="Actual">June 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease-free Survival After Prolonged Endocrine Treatment</measure>
    <time_frame>DFS was defined as the time from two years after randomization to the earliest occurrence of loco-regional recurrence, distant recurrence, contralateral new breast cancer, second cancer or death from any cause, assessed up to a maximum of 8.5 years</time_frame>
    <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of disease-free survival.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall Survival After Prolonged Endocrine Treatment</measure>
    <time_frame>Overall survival was defined as the time from two years after randomization to death due to any cause, assessed up to a maximum of 8.5 years</time_frame>
    <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of overall survival.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to First Clinical Fracture</measure>
    <time_frame>Time to first clinical fracture was defined as time to first clinical fracture, in the period from 2 years until 5 years after randomization for each patient.</time_frame>
    <description>To determine the effect of 2 years versus 5 years of additional Anastrozole after 5 years of adjuvant endocrine therapy on the time to first clinical fracture. Patients without clinical fractures where censored at their last therapy visit (approximately 5 years after randomization).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Secondary Carcinoma</measure>
    <time_frame>Risk of secondary carcinoma was defined as the time from two years after randomization to first occurrence of new secondary cancer without new breast cancer (local or contralateral), assessed up to a maximum of 8.5 years</time_frame>
    <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of lowering the risk of secondary carcinoma. Subjects without secondary cancer event were censored at the last date when they were known to be secondary cancer free.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Contralateral Breast Cancer</measure>
    <time_frame>Risk of contralateral breast cancer was defined as the time from two years after randomization to first occurrence of new contralateral breast cancer, assessed up to a maximum of 8.5 years</time_frame>
    <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of lowering the risk of contralateral breast cancer. Subjects without contralateral breast cancer event were censored at the last date when they were known to be contralateral breast cancer free.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3484</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Arm A: Anastrozol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mg per day for 2 years</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B: Anastrozol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 mg per day for 5 years</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anastrozole</intervention_name>
    <description>1mg tablet daily</description>
    <arm_group_label>Arm A: Anastrozol</arm_group_label>
    <arm_group_label>Arm B: Anastrozol</arm_group_label>
    <other_name>Arimidex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. Postmenopausal patients with histologically confirmed, local radically treated
             invasive or minimal-invasiv Mammacarcinom with or without previous chemotherapie
             and/or radiotherapie.

          2. No distant metastasis at randomization

          3. No relapse at randomization

          4. TNM- classification at time of diagnosis: T1-3, N0 and N+, M0

          5. Estrogen- and or progesterone positive before the beginningof primary endocrine
             therapy

          6. Endocrine therapy for 5 years (maximum deviation ±12 months)

          7. Therapy break (from the preliminary therapie) maximum 12 months.

          8. Informed Consent before the randomisation

        Exclusion criteria:

          1. Premenopausal patients or patients with non definable menopausal statusat time of
             randomisation

          2. Apparent secondary malignant tumor or status after secondary malignant tumor
             (Exceptions: simultaniously appearing bilateral breast carcinoma, estrogen- and or
             progesteronereceptor positive on both sides at the time of diagnosis; in situ
             carcinomaof the cervix and basal cell carcinoma of the skin)

          3. General contraindication respectively hypersensitivity to Anastrozol.

          4. In-situ carcinoma of any size with or without Mb. Paget of the Mamilla respectively T4
             tumor at the time of first diagnosis.

          5. Receptor unknown or negative at time of diagnosis respectively at beginning of primary
             endocrine therapy

          6. Known liver- and/or kidneyinsufficiency

          7. Performance Index &gt;2 according to WHO

          8. Regular intake of hormon supplement as well as Hormone Replacement Therapy (HRT) more
             than 6 months since primary surgery of the mamma carcinoma

          9. Serious accessory disease, that prevents the adjuvant therapy according to protocol
             and/or the regular follow-up care.

         10. Lacking compliance of the patient

         11. Legal incompetence and/or other circumstances, that prevent the patient from
             understanding the nature, meaning and consequences of the clinical trial

         12. Existing psychiatrical diseaseaccording to ICD (especially alcohol addiction) et the
             time of admission into the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AstraZeneca Austria Medical Director, MD</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Amstetten</city>
        <zip>3300</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Bad Ischl</city>
        <zip>4820</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Baden</city>
        <zip>2500</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Bregenz</city>
        <zip>6900</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Dornbirn</city>
        <zip>6853</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Eisenstadt</city>
        <zip>7000</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Feldbach</city>
        <zip>8330</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Feldkirch</city>
        <zip>6807</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Freistadt</city>
        <zip>4240</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Fuerstenfeld</city>
        <zip>8280</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Gmunden</city>
        <zip>4810</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Guessing</city>
        <zip>7540</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Hainburg</city>
        <zip>2410</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Hall in Tirol</city>
        <zip>6060</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kirchdorf</city>
        <zip>4560</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Klagenfurt</city>
        <zip>8020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Klagenfurt</city>
        <zip>9020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Klagenfurt</city>
        <zip>9026</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Krems</city>
        <zip>3500</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kufstein</city>
        <zip>6330</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Leoben</city>
        <zip>8700</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Lienz</city>
        <zip>9900</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Linz</city>
        <zip>4010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Linz</city>
        <zip>4021</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Mistelbach</city>
        <zip>2130</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Moedling</city>
        <zip>2340</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Neunkirchen</city>
        <zip>2620</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Oberpullendorf</city>
        <zip>7350</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Oberwart</city>
        <zip>7400</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ried im Innkreis</city>
        <zip>4910</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Rottenmann</city>
        <zip>8786</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Scheibbs</city>
        <zip>3270</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Schladming</city>
        <zip>8970</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Schwarzach</city>
        <zip>5620</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>St. Poelten</city>
        <zip>3100</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>St. Veit an der Glan</city>
        <zip>9300</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Steyr</city>
        <zip>4400</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Vienna</city>
        <zip>1050</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Vienna</city>
        <zip>1070</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Vienna</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Vienna</city>
        <zip>1210</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Vienna</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Villach</city>
        <zip>9500</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Villach</city>
        <zip>9504</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Voecklabruck</city>
        <zip>4840</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Waidhofen an der Thaya</city>
        <zip>3830</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Weiz</city>
        <zip>8160</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wels</city>
        <zip>4600</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wiener Neustadt</city>
        <zip>2700</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wien</city>
        <zip>1021</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wien</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wien</city>
        <zip>1140</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wien</city>
        <zip>1160</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wien</city>
        <zip>1180</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wien</city>
        <zip>1220</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Wolfsberg</city>
        <zip>9400</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Zams</city>
        <zip>6511</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <link>
    <url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&amp;studyid=2464&amp;filename=1033AU0003_CSP_redacted.pdf</url>
    <description>1033AU/0003 CSP redacted</description>
  </link>
  <link>
    <url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&amp;studyid=2464&amp;filename=1033AU0003_SAP_redacted.pdf</url>
    <description>1033AU/0003 SAP redacted</description>
  </link>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>February 23, 2006</study_first_submitted>
  <study_first_submitted_qc>February 23, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2006</study_first_posted>
  <results_first_submitted>December 14, 2018</results_first_submitted>
  <results_first_submitted_qc>October 1, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">October 2, 2019</results_first_posted>
  <last_update_submitted>October 1, 2019</last_update_submitted>
  <last_update_submitted_qc>October 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hormone receptor positive breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anastrozole</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 27, 2009</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/20/NCT00295620/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 28, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/20/NCT00295620/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The first patient was randomized Feb 26, 2004, the last patient was randomized June 30, 2010. Randomization took place in 75 Austrian clinical sites. In total, 3,484 patients were enrolled.</recruitment_details>
      <pre_assignment_details>Fourteen patients did not sign the Informed Consent, resulting in 3,470 patients who started the trial.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm A: Anastrozol</title>
          <description>1 mg per day for 2 years</description>
        </group>
        <group group_id="P2">
          <title>Arm B: Anastrozol</title>
          <description>1 mg per day for 5 years</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1732"/>
                <participants group_id="P2" count="1738"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Safety Analysis Set</title>
              <participants_list>
                <participants group_id="P1" count="1705"/>
                <participants group_id="P2" count="1710"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="860"/>
                <participants group_id="P2" count="842"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="872"/>
                <participants group_id="P2" count="896"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="206"/>
                <participants group_id="P2" count="207"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other reasons</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Discontinuation by sponsor</title>
              <participants_list>
                <participants group_id="P1" count="580"/>
                <participants group_id="P2" count="593"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="32"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Arm A: Anastrozol</title>
          <description>1 mg per day for 2 years</description>
        </group>
        <group group_id="B2">
          <title>Arm B: Anastrozol</title>
          <description>1 mg per day for 5 years</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1732"/>
            <count group_id="B2" value="1738"/>
            <count group_id="B3" value="3470"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65" lower_limit="58" upper_limit="70"/>
                    <measurement group_id="B2" value="64" lower_limit="59" upper_limit="69"/>
                    <measurement group_id="B3" value="64" lower_limit="59" upper_limit="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1732"/>
                    <measurement group_id="B2" value="1738"/>
                    <measurement group_id="B3" value="3470"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>pN-stage</title>
          <description>Categories of affected lymph nodes:
pN0: no affected lymph nodes, pN1: 1-3 affected lymph nodes, pN2: 4-9 affected lymph nodes, pN3: 10 or more affected lymph nodes</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>pN0</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1140"/>
                    <measurement group_id="B2" value="1162"/>
                    <measurement group_id="B3" value="2302"/>
                  </measurement_list>
                </category>
                <category>
                  <title>pN1</title>
                  <measurement_list>
                    <measurement group_id="B1" value="551"/>
                    <measurement group_id="B2" value="523"/>
                    <measurement group_id="B3" value="1074"/>
                  </measurement_list>
                </category>
                <category>
                  <title>pN2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="71"/>
                  </measurement_list>
                </category>
                <category>
                  <title>pN3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>pT-stage</title>
          <description>Categories of tumor size:
pT1: &lt;2 cm, pT2: 2 to 5 cm, pT3: &gt; 5 cm, pTx: not determinable</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>pT1</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1254"/>
                    <measurement group_id="B2" value="1254"/>
                    <measurement group_id="B3" value="2508"/>
                  </measurement_list>
                </category>
                <category>
                  <title>pT2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="440"/>
                    <measurement group_id="B2" value="442"/>
                    <measurement group_id="B3" value="882"/>
                  </measurement_list>
                </category>
                <category>
                  <title>pT3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
                <category>
                  <title>pTx</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Chemotherapy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Chemotherapy containing anthracycline</title>
                  <measurement_list>
                    <measurement group_id="B1" value="246"/>
                    <measurement group_id="B2" value="236"/>
                    <measurement group_id="B3" value="482"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Chemotherapy containing taxane</title>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="188"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other chemotherapy</title>
                  <measurement_list>
                    <measurement group_id="B1" value="167"/>
                    <measurement group_id="B2" value="163"/>
                    <measurement group_id="B3" value="330"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No chemotherapy</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1224"/>
                    <measurement group_id="B2" value="1241"/>
                    <measurement group_id="B3" value="2465"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Endocrine Therapy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>2 years of anti-estrogen + 3 years Anastrozole</title>
                  <measurement_list>
                    <measurement group_id="B1" value="416"/>
                    <measurement group_id="B2" value="419"/>
                    <measurement group_id="B3" value="835"/>
                  </measurement_list>
                </category>
                <category>
                  <title>5 years of anti-estrogen</title>
                  <measurement_list>
                    <measurement group_id="B1" value="855"/>
                    <measurement group_id="B2" value="862"/>
                    <measurement group_id="B3" value="1717"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Another, comparable endocrine therapy</title>
                  <measurement_list>
                    <measurement group_id="B1" value="459"/>
                    <measurement group_id="B2" value="454"/>
                    <measurement group_id="B3" value="913"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Estrogen Receptor Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Negative</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                    <measurement group_id="B2" value="46"/>
                    <measurement group_id="B3" value="91"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Positive (+/++/+++)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1686"/>
                    <measurement group_id="B2" value="1689"/>
                    <measurement group_id="B3" value="3375"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Progesterone Receptor Status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Negative</title>
                  <measurement_list>
                    <measurement group_id="B1" value="332"/>
                    <measurement group_id="B2" value="356"/>
                    <measurement group_id="B3" value="688"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Positive (+/++/+++)</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1398"/>
                    <measurement group_id="B2" value="1375"/>
                    <measurement group_id="B3" value="2773"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Surgery Type</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Breast-conserving surgery</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1360"/>
                    <measurement group_id="B2" value="1405"/>
                    <measurement group_id="B3" value="2765"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Modified radical mastectomy</title>
                  <measurement_list>
                    <measurement group_id="B1" value="367"/>
                    <measurement group_id="B2" value="319"/>
                    <measurement group_id="B3" value="686"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sentinel Node Biopsy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="900"/>
                    <measurement group_id="B2" value="887"/>
                    <measurement group_id="B3" value="1787"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="820"/>
                    <measurement group_id="B2" value="836"/>
                    <measurement group_id="B3" value="1656"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Axillary Surgery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="386"/>
                    <measurement group_id="B2" value="405"/>
                    <measurement group_id="B3" value="791"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1345"/>
                    <measurement group_id="B2" value="1331"/>
                    <measurement group_id="B3" value="2676"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tumor Grading</title>
          <description>Grade of differentiation:
G1: well differentiated (cells look more like normal breast tissue), G2: moderately differentiated, G3: poorly differentiated, GX: not determinable</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>G1</title>
                  <measurement_list>
                    <measurement group_id="B1" value="247"/>
                    <measurement group_id="B2" value="261"/>
                    <measurement group_id="B3" value="508"/>
                  </measurement_list>
                </category>
                <category>
                  <title>G2</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1107"/>
                    <measurement group_id="B2" value="1090"/>
                    <measurement group_id="B3" value="2197"/>
                  </measurement_list>
                </category>
                <category>
                  <title>G3</title>
                  <measurement_list>
                    <measurement group_id="B1" value="326"/>
                    <measurement group_id="B2" value="348"/>
                    <measurement group_id="B3" value="674"/>
                  </measurement_list>
                </category>
                <category>
                  <title>GX</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Radiotherapy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="1732"/>
                    <count group_id="B2" value="1738"/>
                    <count group_id="B3" value="3470"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>No</title>
                  <measurement_list>
                    <measurement group_id="B1" value="356"/>
                    <measurement group_id="B2" value="327"/>
                    <measurement group_id="B3" value="683"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Yes</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1373"/>
                    <measurement group_id="B2" value="1407"/>
                    <measurement group_id="B3" value="2780"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Disease-free Survival After Prolonged Endocrine Treatment</title>
        <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of disease-free survival.</description>
        <time_frame>DFS was defined as the time from two years after randomization to the earliest occurrence of loco-regional recurrence, distant recurrence, contralateral new breast cancer, second cancer or death from any cause, assessed up to a maximum of 8.5 years</time_frame>
        <population>Per-Protocol (PP) Population, defined as all randomized patients who signed the informed consent who complied with the inclusion and exclusion criteria, who had at least one follow-up examination after randomization and who survived without recurrence for two years.</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Anastrozol</title>
            <description>1 mg per day for 2 years</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Anastrozol</title>
            <description>1 mg per day for 5 years</description>
          </group>
        </group_list>
        <measure>
          <title>Disease-free Survival After Prolonged Endocrine Treatment</title>
          <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of disease-free survival.</description>
          <population>Per-Protocol (PP) Population, defined as all randomized patients who signed the informed consent who complied with the inclusion and exclusion criteria, who had at least one follow-up examination after randomization and who survived without recurrence for two years.</population>
          <units>Years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1281"/>
                <count group_id="O2" value="1323"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="7.7" upper_limit="NA">NA – Not applicable, estimates cannot be calculated due to too few events.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="8.1" upper_limit="NA">NA – Not applicable, estimates cannot be calculated due to too few events.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Arm A: Anastrozole for 2 yerars Arm B: Anastrozole for 5 years Null hypothesis: there is no difference between the two treatment arms in the probability of a DFS event</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.425</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.93</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.79</ci_lower_limit>
            <ci_upper_limit>1.11</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Survival After Prolonged Endocrine Treatment</title>
        <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of overall survival.</description>
        <time_frame>Overall survival was defined as the time from two years after randomization to death due to any cause, assessed up to a maximum of 8.5 years</time_frame>
        <population>All randomized patients who signed the informed consent and who did not die during two first two years</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Anastrozol</title>
            <description>1 mg per day for 2 years</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Anastrozol</title>
            <description>1 mg per day for 5 years</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Survival After Prolonged Endocrine Treatment</title>
          <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of overall survival.</description>
          <population>All randomized patients who signed the informed consent and who did not die during two first two years</population>
          <units>Years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1665"/>
                <count group_id="O2" value="1670"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">NA – Not applicable, estimates cannot be calculated due to too few events.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">NA – Not applicable, estimates cannot be calculated due to too few events.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Arm A: Anastrozole for 2 yerars Arm B: Anastrozole for 5 years Null hypothesis: there is no difference between the two treatment arms in the probability of a death event</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.867</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.02</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.83</ci_lower_limit>
            <ci_upper_limit>1.25</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First Clinical Fracture</title>
        <description>To determine the effect of 2 years versus 5 years of additional Anastrozole after 5 years of adjuvant endocrine therapy on the time to first clinical fracture. Patients without clinical fractures where censored at their last therapy visit (approximately 5 years after randomization).</description>
        <time_frame>Time to first clinical fracture was defined as time to first clinical fracture, in the period from 2 years until 5 years after randomization for each patient.</time_frame>
        <population>All randomized patients who signed the informed consent and who had no fractures during the first two years</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Anastrozol</title>
            <description>1 mg per day for 2 years</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Anastrozol</title>
            <description>1 mg per day for 5 years</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First Clinical Fracture</title>
          <description>To determine the effect of 2 years versus 5 years of additional Anastrozole after 5 years of adjuvant endocrine therapy on the time to first clinical fracture. Patients without clinical fractures where censored at their last therapy visit (approximately 5 years after randomization).</description>
          <population>All randomized patients who signed the informed consent and who had no fractures during the first two years</population>
          <units>Years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1555"/>
                <count group_id="O2" value="1570"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">NA – Not applicable, estimates cannot be calculated due to too few events.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">NA – Not applicable, estimates cannot be calculated due to too few events.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Arm A: Anastrozole for 2 yerars Arm B: Anastrozole for 5 years Null hypothesis: there is no difference between the two treatment arms in the probability of a fracture</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.052</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.35</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.00</ci_lower_limit>
            <ci_upper_limit>1.84</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Secondary Carcinoma</title>
        <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of lowering the risk of secondary carcinoma. Subjects without secondary cancer event were censored at the last date when they were known to be secondary cancer free.</description>
        <time_frame>Risk of secondary carcinoma was defined as the time from two years after randomization to first occurrence of new secondary cancer without new breast cancer (local or contralateral), assessed up to a maximum of 8.5 years</time_frame>
        <population>All randomized patients who signed the informed consent and had no secondary carcinoma (excluding contralateral mammacarcinoma) during the first two years</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Anastrozol</title>
            <description>1 mg per day for 2 years</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Anastrozol</title>
            <description>1 mg per day for 5 years</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Secondary Carcinoma</title>
          <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of lowering the risk of secondary carcinoma. Subjects without secondary cancer event were censored at the last date when they were known to be secondary cancer free.</description>
          <population>All randomized patients who signed the informed consent and had no secondary carcinoma (excluding contralateral mammacarcinoma) during the first two years</population>
          <units>Years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1620"/>
                <count group_id="O2" value="1620"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">NA – Not applicable, estimates cannot be calculated due to too few events.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">NA – Not applicable, estimates cannot be calculated due to too few events.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Arm A: Anastrozole for 2 yerars Arm B: Anastrozole for 5 years Null hypothesis: there is no difference between the two treatment arms in the probability of the occurrence of secondary carcinoma</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.678</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.06</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.81</ci_lower_limit>
            <ci_upper_limit>1.38</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Contralateral Breast Cancer</title>
        <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of lowering the risk of contralateral breast cancer. Subjects without contralateral breast cancer event were censored at the last date when they were known to be contralateral breast cancer free.</description>
        <time_frame>Risk of contralateral breast cancer was defined as the time from two years after randomization to first occurrence of new contralateral breast cancer, assessed up to a maximum of 8.5 years</time_frame>
        <population>All randomized patients who signed the informed consent and had no contralateral mammacarcinoma during the first two years</population>
        <group_list>
          <group group_id="O1">
            <title>Arm A: Anastrozol</title>
            <description>1 mg per day for 2 years</description>
          </group>
          <group group_id="O2">
            <title>Arm B: Anastrozol</title>
            <description>1 mg per day for 5 years</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Contralateral Breast Cancer</title>
          <description>To determine whether 5 years of additional Anastrozole was more effective than 2 years of additional Anastrozole after 5 years of adjuvant endocrine therapy in terms of lowering the risk of contralateral breast cancer. Subjects without contralateral breast cancer event were censored at the last date when they were known to be contralateral breast cancer free.</description>
          <population>All randomized patients who signed the informed consent and had no contralateral mammacarcinoma during the first two years</population>
          <units>Years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1636"/>
                <count group_id="O2" value="1641"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA" lower_limit="NA" upper_limit="NA">NA – Not applicable, estimates cannot be calculated due to too few events.</measurement>
                    <measurement group_id="O2" value="NA" lower_limit="NA" upper_limit="NA">NA – Not applicable, estimates cannot be calculated due to too few events.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Arm A: Anastrozole for 2 years Arm B: Anastrozole for 5 years Null hypothesis: there is no difference between the two treatment arms in the probability of the occurrence of contralateral mammacarcinoma</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.531</p_value>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.15</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.75</ci_lower_limit>
            <ci_upper_limit>1.77</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Maximum observation period per patient 10.5 years; reporting period for all-cause mortality starts with randomization; adverse event reporting starts with first dose of treatment</time_frame>
      <desc>All-cause mortality data presented for intention-to-treat analysis set and for the entire study. Serious adverse events (SAEs) reported during treatment phase plus 30 days, and after this period only if the investigator could not preclude a causal link to treatment with Anastrozole. SAEs are based on the safety population (randomized and received at least one dose of study treatment). Other adverse events were not collected in the safety database and are therefore not reported here.</desc>
      <group_list>
        <group group_id="E1">
          <title>Arm B: Anastrozol - 1 mg Per Day for 5 Years</title>
          <description>Description (Arm-group)</description>
        </group>
        <group group_id="E2">
          <title>Arm A: Anastrozol - 1 mg Per Day for 2 Years</title>
          <description>Description (Arm-group)</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="207" subjects_at_risk="1738"/>
                <counts group_id="E2" subjects_affected="207" subjects_at_risk="1732"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="687" subjects_at_risk="1710"/>
                <counts group_id="E2" subjects_affected="452" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Anaemia macrocytic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bone marrow oedema</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Haemolytic anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Immune thrombocytopenic purpura</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lymph node calcification</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mastocytosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spontaneous haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="9" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Aortic valve disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Aortic valve prolapse</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Aortic valve stenosis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis coronary artery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="37" subjects_affected="17" subjects_at_risk="1710"/>
                <counts group_id="E2" events="10" subjects_affected="6" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Atrioventricular block complete</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="15" subjects_affected="7" subjects_at_risk="1710"/>
                <counts group_id="E2" events="12" subjects_affected="6" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cardiac flutter</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cor pulmonale chronic</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="17" subjects_affected="8" subjects_at_risk="1710"/>
                <counts group_id="E2" events="13" subjects_affected="6" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mitral valve disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mitral valve disease mixed</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pulmonary valve incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Right ventricular failure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sinus node dysfunction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="9" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tachycardia paroxysmal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tricuspid valve incompetence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Wolff-parkinson-white syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Adenomatous polyposis coli</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Anomalous arrangement of pancreaticobiliary duct</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Choledochal cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Congenital uterine anomaly</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Corneal opacity congenital</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Developmental hip dysplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Epidermal naevus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Foramen magnum stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Cupulolithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Deafness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Deafness unilateral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Inner ear disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Meniere's disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tympanosclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="15" subjects_affected="8" subjects_at_risk="1710"/>
                <counts group_id="E2" events="9" subjects_affected="5" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vertigo positional</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="22" subjects_affected="12" subjects_at_risk="1710"/>
                <counts group_id="E2" events="8" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism primary</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Thyroid haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Age-related macular degeneration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Astigmatism</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Blepharochalasis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="68" subjects_affected="26" subjects_at_risk="1710"/>
                <counts group_id="E2" events="26" subjects_affected="12" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cataract cortical</sub_title>
                <counts group_id="E1" events="10" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cataract nuclear</sub_title>
                <counts group_id="E1" events="5" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dacryostenosis acquired</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Exfoliation syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Eye haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lens dislocation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Macular degeneration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Macular hole</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Maculopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Myopia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Photopsia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Retinal artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Retinal degeneration</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Retinal disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Retinal haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Retinal tear</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Retinopathy hypertensive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vitreous haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="22" subjects_affected="13" subjects_at_risk="1710"/>
                <counts group_id="E2" events="12" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="7" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Abdominal symptom</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Abdominal wall disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Abnormal faeces</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Acute abdomen</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Anal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Anal incontinence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Anal polyp</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Anorectal discomfort</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Anorectal disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Chronic gastritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Coeliac disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Colitis microscopic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Colitis ulcerative</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dental alveolar anomaly</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="21" subjects_affected="12" subjects_at_risk="1710"/>
                <counts group_id="E2" events="11" subjects_affected="6" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Diarrhoea haemorrhagic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Diverticular perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal</sub_title>
                <counts group_id="E1" events="12" subjects_affected="6" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Duodenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Enterocele</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Erosive duodenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastric polyps</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastric ulcer haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="10" subjects_affected="5" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastritis erosive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" events="10" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="10" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Inflammatory bowel disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intestinal fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intestinal polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intestinal prolapse</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Large intestine polyp</sub_title>
                <counts group_id="E1" events="28" subjects_affected="16" subjects_at_risk="1710"/>
                <counts group_id="E2" events="17" subjects_affected="8" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mallory-weiss syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mouth haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="13" subjects_affected="7" subjects_at_risk="1710"/>
                <counts group_id="E2" events="14" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pancreatic cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pancreatitis necrotising</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Proctitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rectal polyp</sub_title>
                <counts group_id="E1" events="10" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tooth disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="10" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Calcinosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="19" subjects_affected="9" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Condition aggravated</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="12" subjects_affected="6" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fat necrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hyperplasia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ill-defined disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Implant site extravasation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Implant site fibrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Incarcerated hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Multiple organ dysfunction syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Oedema mucosal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Polyp</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sudden cardiac death</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Ampulla of vater stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bile duct stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Biliary tract disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="27" subjects_affected="14" subjects_at_risk="1710"/>
                <counts group_id="E2" events="27" subjects_affected="15" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gallbladder disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hepatic cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hepatic steatosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hepatitis cholestatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Non-alcoholic steatohepatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy to arthropod bite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Abdominal wall abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Abscess of salivary gland</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Campylobacter gastroenteritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Chest wall abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="16" subjects_affected="7" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Diverticulitis intestinal haemorrhagic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Encephalitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="13" subjects_affected="6" subjects_at_risk="1710"/>
                <counts group_id="E2" events="10" subjects_affected="7" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Extradural abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Helicobacter gastritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Infected dermal cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Meningitis viral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Neuroborreliosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Osteomyelitis acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="22" subjects_affected="11" subjects_at_risk="1710"/>
                <counts group_id="E2" events="12" subjects_affected="5" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pyometra</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Salpingitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sinobronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Urethral carbuncle</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="23" subjects_affected="11" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vaginal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vulval abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Acetabulum fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Anaemia postoperative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="38" subjects_affected="20" subjects_at_risk="1710"/>
                <counts group_id="E2" events="9" subjects_affected="5" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bankart lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bone contusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Compression fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="18" subjects_affected="10" subjects_at_risk="1710"/>
                <counts group_id="E2" events="10" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Coronary bypass thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Craniocerebral injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Facial bones fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Femoral neck fracture</sub_title>
                <counts group_id="E1" events="9" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="12" subjects_affected="8" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fibula fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="14" subjects_affected="7" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Forearm fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fracture</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fractured sacrum</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" events="12" subjects_affected="6" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" events="24" subjects_affected="13" subjects_at_risk="1710"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ilium fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="6" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Incisional hernia, obstructive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intestinal anastomosis complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Keratorhexis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ligament injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="11" subjects_affected="5" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Meniscus injury</sub_title>
                <counts group_id="E1" events="27" subjects_affected="14" subjects_at_risk="1710"/>
                <counts group_id="E2" events="8" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Multiple injuries</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Muscle injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Neck injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Patella fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Postoperative wound complication</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pubis fracture</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Radiation oesophagitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" events="55" subjects_affected="29" subjects_at_risk="1710"/>
                <counts group_id="E2" events="40" subjects_affected="21" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Scapula fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Skin injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Stress fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Suture related complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tendon rupture</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Traumatic fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Traumatic lung injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ulna fracture</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Wrist fracture</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Angiogram</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Biopsy lymph gland</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Blood glucose abnormal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bronchoscopy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Carcinoembryonic antigen increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Colonoscopy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Electrocardiogram change</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Endoscopic retrograde cholangiopancreatography</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Endoscopy upper gastrointestinal tract</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lipids abnormal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Occult blood positive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Smear cervix abnormal</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tumour marker increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Varicella virus test positive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Calciphylaxis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Glucose tolerance impaired</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hypercholesterolaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hyperlipidaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Type 2 diabetes mellitus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="7" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Arthrofibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="13" subjects_affected="7" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Chondropathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" events="28" subjects_affected="14" subjects_at_risk="1710"/>
                <counts group_id="E2" events="30" subjects_affected="14" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="29" subjects_affected="15" subjects_at_risk="1710"/>
                <counts group_id="E2" events="15" subjects_affected="9" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Joint range of motion decreased</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Joint stiffness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Musculoskeletal disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Myosclerosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="164" subjects_affected="74" subjects_at_risk="1710"/>
                <counts group_id="E2" events="60" subjects_affected="29" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Osteochondrosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Osteoporosis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="8" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Osteoporotic fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="7" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Plica syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rheumatic disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rheumatoid arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="9" subjects_affected="5" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spinal deformity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spinal fusion acquired</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spinal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="10" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Synovitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tendon pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tenosynovitis stenosans</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Trigger finger</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vertebral foraminal stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma gastric</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma of colon</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Adenoma benign</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Adrenal adenoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Angiomyolipoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Angiosarcoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>B-cell lymphoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>B-cell small lymphocytic lymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" events="19" subjects_affected="8" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Benign breast neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bladder papilloma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bladder transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bowen's disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast angiosarcoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" events="22" subjects_affected="13" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast cancer female</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast cancer in situ</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast cancer metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast cancer recurrent</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast neoplasm</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bronchial carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour of the caecum</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour of the stomach</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cardiac neoplasm unspecified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cholesteatoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Chronic myeloid leukaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Clear cell renal cell carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" events="8" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Diffuse large b-cell lymphoma stage i</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Enchondromatosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Endometrial adenocarcinoma</sub_title>
                <counts group_id="E1" events="6" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Endometrial cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Essential thrombocythaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fallopian tube cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fallopian tube cancer metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Fibroma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gallbladder cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastric neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Glioblastoma multiforme</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Glomus tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Haemangioma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Haemangioma of breast</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hodgkin's disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haemangioma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intraductal proliferative breast lesion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Invasive breast carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Invasive ductal breast carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Invasive lobular breast carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Leiomyoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" events="12" subjects_affected="6" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Malignant melanoma stage iv</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm of uterine adnexa</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Malignant peritoneal neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Meningeal neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mesothelioma malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Metastases to abdominal cavity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Metastases to breast</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Metastasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Metastatic bronchial carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mucinous breast carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Neoplasm</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Neoplasm skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Neuroendocrine carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Neuroendocrine tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Non-hodgkin's lymphoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Oral fibroma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Osteochondroma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ovarian adenoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ovarian cancer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma metastatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Papillary thyroid cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Parathyroid tumour benign</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Plasma cell myeloma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rectal adenocarcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rectal adenoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Renal cancer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rosai-dorfman syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sarcoma uterus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Skin papilloma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Small intestine adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of lung</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of skin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma of the cervix</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Superficial spreading melanoma stage ii</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Superficial spreading melanoma stage unspecified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Thyroid adenoma</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Transitional cell carcinoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Uterine leiomyoma</sub_title>
                <counts group_id="E1" events="15" subjects_affected="6" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Autonomic nervous system imbalance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Brain stem infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Burning feet syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Carotid artery aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="18" subjects_affected="10" subjects_at_risk="1710"/>
                <counts group_id="E2" events="23" subjects_affected="10" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="12" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cervical radiculopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="7" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dysaesthesia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Embolic cerebral infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Facial paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Generalised tonic-clonic seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Horner's syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hypertonia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ischaemic cerebral infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mental impairment</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Myelopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Nerve root compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Neuromuscular blockade</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Paralysis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Peroneal nerve palsy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Quadriparesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Radicular pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ruptured cerebral aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" events="20" subjects_affected="10" subjects_at_risk="1710"/>
                <counts group_id="E2" events="17" subjects_affected="9" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Speech disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="17" subjects_affected="9" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tension headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Thalamic infarction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" events="15" subjects_affected="8" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Trigeminal neuralgia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vertigo cns origin</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Visual pathway disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vocal cord paresis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device breakage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Adjustment disorder with depressed mood</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Anxiety disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bipolar disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Burnout syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="13" subjects_affected="7" subjects_at_risk="1710"/>
                <counts group_id="E2" events="12" subjects_affected="6" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intentional self-injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Persistent depressive disorder</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Schizoaffective disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Schizoaffective disorder depressive type</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Somatic symptom disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute kidney injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Micturition disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Renal aneurysm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Renal artery stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Renal mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Renal pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ureteric stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Urethral haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" events="8" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Adenomyosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Adnexa uteri cyst</sub_title>
                <counts group_id="E1" events="5" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast calcifications</sub_title>
                <counts group_id="E1" events="10" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast disorder</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast fibrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast hyperplasia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast mass</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cervical dysplasia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cervical polyp</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Colpocele</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cystocele</sub_title>
                <counts group_id="E1" events="6" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ectropion of cervix</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Endometrial atrophy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Endometrial disorder</sub_title>
                <counts group_id="E1" events="12" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Endometrial hyperplasia</sub_title>
                <counts group_id="E1" events="39" subjects_affected="16" subjects_at_risk="1710"/>
                <counts group_id="E2" events="16" subjects_affected="6" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Endometrial metaplasia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hydrometra</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Menometrorrhagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Nipple exudate bloody</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ovarian cyst</sub_title>
                <counts group_id="E1" events="17" subjects_affected="8" subjects_at_risk="1710"/>
                <counts group_id="E2" events="17" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Ovarian disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" events="22" subjects_affected="11" subjects_at_risk="1710"/>
                <counts group_id="E2" events="19" subjects_affected="9" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rectocele</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Uterine disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Uterine polyp</sub_title>
                <counts group_id="E1" events="51" subjects_affected="16" subjects_at_risk="1710"/>
                <counts group_id="E2" events="17" subjects_affected="6" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Uterine prolapse</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Uterovaginal prolapse</sub_title>
                <counts group_id="E1" events="10" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vaginal cyst</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vaginal dysplasia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="12" subjects_affected="7" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vaginal polyp</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vaginal prolapse</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vaginal stricture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vulva cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bronchial polyp</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="11" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="17" subjects_affected="9" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hyperventilation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hypoventilation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Nasal turbinate abnormality</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Nocturnal dyspnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="7" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pulmonary artery thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="27" subjects_affected="14" subjects_at_risk="1710"/>
                <counts group_id="E2" events="8" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Pulmonary vascular disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="7" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sinus disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Actinic keratosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="12" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dermal cyst</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Excessive granulation tissue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hidradenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lichen sclerosus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Psoriasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Sebaceous gland disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Skin necrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="7" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Urticaria chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Alcohol rehabilitation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Angioplasty</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Aortic valve replacement</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Arthrodesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Breast reconstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Bunion operation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cancer surgery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker insertion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cardiac pacemaker replacement</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Carpal tunnel decompression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cataract operation</sub_title>
                <counts group_id="E1" events="6" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Central venous catheter removal</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Cholecystectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Colostomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Enterostomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Eye operation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Gastric banding</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hernia repair</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hip arthroplasty</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hysterectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hysterosalpingo-oophorectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intraocular lens implant</sub_title>
                <counts group_id="E1" events="6" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Jaw operation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Joint arthroplasty</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Knee arthroplasty</sub_title>
                <counts group_id="E1" events="10" subjects_affected="5" subjects_at_risk="1710"/>
                <counts group_id="E2" events="6" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Knee operation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Large intestinal polypectomy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lipoma excision</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lithotripsy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lymphadenectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mammoplasty</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Medical device removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Mole excision</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Nasal operation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Nephrectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Oophorectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Oophorectomy bilateral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Plastic surgery</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Posterior lens capsulotomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Postoperative care</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Radioactive iodine therapy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Rectal polypectomy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Renal cyst excision</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Salpingo-oophorectomy bilateral</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Scar excision</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Skin graft</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spinal decompression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Spinal operation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Synovectomy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Synovial cyst removal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tendon operation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Thyreostatic therapy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Thyroidectomy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Toe operation</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Uterine tumour excision</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vaginoperineoplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Varicose vein operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Aortic arteriosclerosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Blood pressure fluctuation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Blood pressure inadequately controlled</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="15" subjects_affected="7" subjects_at_risk="1710"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Embolism arterial</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Extrinsic iliac vein compression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="14" subjects_affected="8" subjects_at_risk="1710"/>
                <counts group_id="E2" events="10" subjects_affected="6" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="27" subjects_affected="13" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" events="8" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Peripheral artery occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Peripheral artery stenosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Peripheral venous disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="8" subjects_affected="4" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Subclavian artery stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Temporal arteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="3" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Varicose vein</sub_title>
                <counts group_id="E1" events="15" subjects_affected="8" subjects_at_risk="1710"/>
                <counts group_id="E2" events="27" subjects_affected="12" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Vein disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1705"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="1710"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1710"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1705"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI/Sponsor collaborate in good faith regarding contents/formation of any PI publication/disclosure; PI pays due consideration to comments/opinions of Sponsor. Prior to any publication PI undertakes to provide Sponsor with preliminary data and drafts of publication/disclosures (oral or written) and with proposed final manuscript. Sponsor can review within 30 days and can require that submission for publication/disclosure of manuscript be delayed in order for Sponsor to file patent applications.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Trial Office Director</name_or_title>
      <organization>ABCSG</organization>
      <phone>+43 1 4089230</phone>
      <email>info@abcsg.at</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

